IOL CHEMICALS & PHARM. | VILIN BIO MED | IOL CHEMICALS & PHARM./ VILIN BIO MED |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.8 | - | - | View Chart |
P/BV | x | 1.6 | 2.7 | 57.0% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. VILIN BIO MED |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
VILIN BIO MED Mar-23 |
IOL CHEMICALS & PHARM./ VILIN BIO MED |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | NA | - | |
Low | Rs | 272 | NA | - | |
Sales per share (Unadj.) | Rs | 377.6 | 12.4 | 3,051.6% | |
Earnings per share (Unadj.) | Rs | 23.7 | 1.3 | 1,894.1% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 1.4 | 2,222.5% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 10.7 | 2,393.0% | |
Shares outstanding (eoy) | m | 58.71 | 9.95 | 590.1% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 0 | - | |
Avg P/E ratio | x | 17.1 | 0 | - | |
P/CF ratio (eoy) | x | 12.8 | 0 | - | |
Price / Book Value ratio | x | 1.6 | 0 | - | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 0 | - | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 8 | 21,648.6% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 123 | 18,006.3% | |
Other income | Rs m | 256 | 0 | 106,708.3% | |
Total revenues | Rs m | 22,427 | 123 | 18,178.8% | |
Gross profit | Rs m | 2,257 | 26 | 8,770.7% | |
Depreciation | Rs m | 462 | 2 | 27,476.2% | |
Interest | Rs m | 165 | 6 | 2,541.7% | |
Profit before tax | Rs m | 1,887 | 18 | 10,586.4% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 5 | 9,219.7% | |
Profit after tax | Rs m | 1,391 | 12 | 11,175.9% | |
Gross profit margin | % | 10.2 | 20.9 | 48.7% | |
Effective tax rate | % | 26.2 | 30.1 | 87.1% | |
Net profit margin | % | 6.3 | 10.1 | 62.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 133 | 7,276.8% | |
Current liabilities | Rs m | 5,025 | 65 | 7,725.1% | |
Net working cap to sales | % | 20.9 | 55.1 | 38.0% | |
Current ratio | x | 1.9 | 2.0 | 94.2% | |
Inventory Days | Days | 43 | 86 | 50.5% | |
Debtors Days | Days | 8 | 2,927 | 0.3% | |
Net fixed assets | Rs m | 11,017 | 44 | 25,039.5% | |
Share capital | Rs m | 587 | 100 | 590.1% | |
"Free" reserves | Rs m | 14,490 | 7 | 199,039.8% | |
Net worth | Rs m | 15,077 | 107 | 14,119.9% | |
Long term debt | Rs m | 0 | 4 | 0.0% | |
Total assets | Rs m | 20,684 | 177 | 11,697.1% | |
Interest coverage | x | 12.5 | 3.8 | 332.1% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.7 | 153.9% | |
Return on assets | % | 7.5 | 10.7 | 70.3% | |
Return on equity | % | 9.2 | 11.7 | 79.2% | |
Return on capital | % | 13.6 | 21.9 | 62.2% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 0 | - | |
Fx outflow | Rs m | 6,052 | 0 | - | |
Net fx | Rs m | -122 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | -17 | -7,374.5% | |
From Investments | Rs m | -1,200 | NA | 400,000.0% | |
From Financial Activity | Rs m | -41 | 17 | -244.1% | |
Net Cashflow | Rs m | -18 | 0 | 46,000.0% |
Indian Promoters | % | 48.2 | 64.5 | 74.7% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | - | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 35.5 | 146.0% | |
Shareholders | 130,003 | 585 | 22,222.7% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | VILIN BIO MED | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.61% | 5.00% | -0.41% |
1-Month | 6.18% | 8.81% | -0.50% |
1-Year | -1.80% | -10.64% | 53.15% |
3-Year CAGR | -12.86% | -3.68% | 14.76% |
5-Year CAGR | 17.52% | -2.22% | 19.69% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the VILIN BIO MED share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of VILIN BIO MED the stake stands at 64.5%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of VILIN BIO MED.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
VILIN BIO MED paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of VILIN BIO MED.
For a sector overview, read our pharmaceuticals sector report.
Asian stocks got off to a positive start on Monday ahead of the Federal Reserve's policy meeting later in the week.